ALLO vs MTCH · rev $22.0K vs P/E 13, rev $3.48B
Allogene Therapeutics Inc (ALLO) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
ALLO currently screens at market cap $258.1M. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the ALLO and MTCH stock pages for the full models.
Not investment advice.